NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.05
+0.04 (0.13%)
Mar 24, 2026, 3:58 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 22.50M | 45.56M | 14.09M | 102.69M | - | |
Biotechnology (Startups) Growth | -50.61% | 223.37% | -86.28% | - | - | |
| 22.50M | 45.56M | 14.09M | 102.69M | - | |
| -50.61% | 223.37% | -86.28% | - | - | |
Source: S&P Global Market Intelligence.